NCT01790997 - Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke | Biotech Hunter

Enrollment

126

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

December 31, 2013

Conditions

Acute Ischemic Stroke

Interventions

DRUG

DLBS1033

1 tablet of DLBS1033 490 mg thrice daily, after meal

DRUG

Aspirin

1 tablet of aspirin 80 mg once daily, after meal

DRUG

Clopidogrel

1 tablet of clopidogrel 75 mg once daily, after meal

Trial Locations (1)

Stroke Unit, Department of Neurology, Faculty of Medicine, Gadjah Mada University, dr. Sardjito Hospital, Yogyakarta